Intelligence Β· Patent portfolio
Vertex Pharmaceuticals (Australia) Patents
Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) β grant dates, expiration, and drug cross-links.
- Patents
- 991
- Expiring β€24m
- 63
Quick answer
Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months β use filters for patent-cliff planning.
-
US 7115739
Triazole compounds useful as protein kinase inhibitors
granted -
US 7109172
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7109215
Compounds possessing neuronal activity
granted -
US 7105546
Acyclic and cyclic amine derivatives
granted -
US 7098330
Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
granted -
US 7091343
Compositions useful as inhibitors of protein kinases
granted -
US 7087603
Pyrazole compounds useful as protein kinase inhibitors
granted -
US 7087642
Inhibitors of IMPDH enzyme
granted -
US 7084159
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
granted -
US 7078209
CAK inhibitors and uses thereof
granted -
US 7074782
Carbamate caspase inhibitors and uses thereof
granted -
US 7056944
Pyrazole compositions useful as inhibitors of erk
granted -
US 7053057
Caspase inhibitors and uses thereof
granted -
US 7041687
Indazole compounds useful as protein kinase inhibitors
expired -
US 7008948
Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
expired -
US 6994868
Compositions useful as inhibitors of ERK
expired -
US 6995141
Interleukin 1Ξ² protease and interleukin 1Ξ² protease inhibitors
expired -
US 6995261
4-pyridazinecarboxamides and esters as interleukin-1Ξ² converting enzyme inhibitors
expired -
US 6989385
Pyrazole compounds useful as protein kinase inhibitors
expired -
US 6974809
Inhibitors of interleukin 1-Ξ² converting enzyme
expired -
US 6967214
Inhibitors of IMPDH enzyme
expired -
US 6962936
Triazole-derived kinase inhibitors and uses thereof
expired -
US 6962996
Inhibitors of p38
expired -
US 6949580
Pyrazole compositions useful as inhibitors of ERK
expired -
US 6949544
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
expired -
US 6930116
Gyrase inhibitors and uses thereof
expired -
US 6916798
Inhibitors of GSK-3 and uses thereof
expired -
US 6909000
Bridged bicyclic serine protease inhibitors
expired -
US 6884804
Inhibitors of Src and other protein kinases
expired -
US 6878728
Inhibitors of aspartyl protease
expired -
US 6875789
Pyrazole-derived kinase inhibitors and uses thereof
expired -
US 6849267
Compositions useful as inhibitors of ERK
expired -
US 6849630
Cyclized amino acid derivatives
expired -
US 6846928
Compositions useful as inhibitors of protein kinases
expired -
US 6838474
Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
expired -
US 6825224
Prodrugs of carbamate inhibitors of IMPDH
expired -
US 6825190
Protein kinase inhibitors and uses thereof
expired -
US 6824769
Optimal compositions and methods thereof for treating HCV infections
expired -
US 6800619
Caspase inhibitors and uses thereof
expired -
US 6800626
Inhibitors of p38
expired -
US 6784195
Pyrazole compositions useful as inhibitors of ERK
expired -
US 6762179
Thiazole compounds useful as inhibitors of protein kinase
expired -
US 6759535
Inhibitors of p38
expired -
US 6750239
Pyrazole-derived kinase inhibitors and uses thereof
expired -
US 6747042
N-heterocyclic derivatives
expired -
US 6743791
Heterocyclic inhibitors of ERK2 and uses thereof
expired -
US 6727251
Pyrazole compounds useful as protein kinase inhibitors
expired -
US 6720335
Sulfonamide inhibitors of aspartyl protease
expired
Frequently asked questions
How many patents does Vertex Pharmaceuticals (Australia) have?
991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Vertex Pharmaceuticals (Australia) patents expire?
63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory